- Home
- / DaVita
DaVita
Stock Price
$154.8
2024-08-26
Market Capitalization
$13 B
2024-08-26
Revenue
$12.1 B
FY, 2023
DaVita Summary
Company Summary
- Overview
- DaVita is a kidney care company focused on dialysis and related lab solutions. It specializes in hemodialysis, peritoneal dialysis, and kidney transplantation. The company provides outpatient hemodialysis, hospital inpatient hemodialysis, and home-based dialysis, ESRD laboratory, and management services.
- Type
- Public
- Status
- Active
- Founded
- 1994
- HQ
- Denver, CO, US | view all locations
- Website
- https://www.davita.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Barbara J Desoer, Director
Charles G Berg, Former Chief Executive Officer, Citibank, N.A.
George R Aronoff, Vice President of Clinical Affairs, Kidney Care
Operating MetricsView all
Hospitals
900
FY, 2019
Dialysis Centers
2.8K
3.3%
FY, 2019
Dialysis Centers Opened Year to Date
89
42.2%
FY, 2019
LocationsView all
24 locations detected
Denver, CO HQ
United States
2000 16th St Mall
Brentwood, TN
United States
5200 Virginia Way
Centennial, CO
United States
7173 S Havana St #100
DeLand, FL
United States
1991 Industrial Dr
DeLand, FL
United States
3000 Davita Way
Denver, CO
United States
1551 Wewatta St
DaVita Financials
Summary Financials
- Revenue (Q2, 2024)
- $3.2B
- Net income (Q2, 2024)
- $299.8M
- Cash (Q2, 2024)
- $416.5M
- EBIT (Q2, 2024)
- $506.4M
- Enterprise value
- $24.2B